Pasireotide lar and octreotide LAR maintain biochemical control in patients with acromegaly: Extension phase of a 12-month randomized, double-blind, multicenter, phase III study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2012
This article has no abstract
Epistemonikos ID: 181839a05f93cff9b3f0fab497ca09e1fc556dd8
First added on: Feb 05, 2025